Geum.ru

Кузин М. И., Гехт Б. М. Миастения

Вид материалаДокументы
Подобный материал:
1   2   3

ссылка скрыта Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice // J. Immunol. – 2000. – V.164. - №10. – P.5236-5244.


Keanes G. The results of thymectomy in myasthenia gravis // Br. Med. J. - 1949. – V.2. - P.611-616.

Kelly J.J., Daube J.R., Lennon V.A., Howard F.M. The laboratory diagnosis of mild myasthenia gravis // Ann. Neurol. Neurosurg. - 1982. – V.12. - P.238-242.

Kennel P.F., Vilquin J.T., Braun S., Fonteneau P., Warter J.M., Poindron P. Myasthenia gravis: comparative autoantibody assays using human muscle, TE671 and glucocorticoid-treated TE671 cells as sources of antigen // Clin. Immunol. Immunopathol. - 1995. - V.74. - P.293-296.

Kim Y.I., Nam T.S., Kim S.H., Viglione M.P., Kim J. Specificity of the Lambert-Eaton syndrome antibodies: downregulation of P/Q-type calcium channels in bovine adrenal chromaffin cells // Ann. N.Y. Acad. Sci. - 1998. – V.841. – P.677-683

Kimura J. Electrodiagnosis in diseases of nerve and muscle: principles and practice. - Philadelphia. - 1989. - 710 p.

ссылка скрыта, ссылка скрыта. Myasthenia gravis appearing after thymectomy for thymoma // Eur. J. Cardiothorac. Surg. – 2005. – V. 28. – P. 22-25.

ссылка скрыта., ссылка скрыта. Thymoma and myasthenia gravis: a clinical study of 1089 patients from Japan // Ann. Thorac. Surg. - 2005. – V.79. - P.219-224.

Krarup С. Electrical and mechanical responses in the platisma and in the adductor pollicis muscle in patients with myasthenia gravis // J. Neurol., Neurosurg., Psychiat. - 1977. - V.40. - P.241-249.

Krarup C. Evoked responses in normal and diseased muscle with particular reference to twitch potentiation // Acta Neurol. Scand. - 1984. - V.68. - P.269-315.

ссылка скрыта Evoked responses of the elbow flexors in control subjects and in myopathy patients // Muscle & Nerve. – 1979. – V.6. – P.465-477.

Kuks J.B., Limburg P.C., Horst G., Dijksterhuis J., Oosterhuis H.J Antibodies to skeletal muscle in myasthenia gravis. Diagnostic value for the detection of thymoma // J. Neurol. Sci. – 1993. – V.119. – P.183-188.

Kuks J.B., Limburg P.C., Horst G., Oosterhuis H.J. Antibodies to skeletal muscle in myastrenia gravis. Prevalence in non-thymoma patiens // J. Neurol. Sci. - 1993. - V.120. - P.78-81.

Labiet S., Kolmerer B. Titin: giant proteins in charge of muscle ultrastructure and elasticity // J. Sci. - 1995. – V.270. – P.293-296.

Lambert E.H., Eaton L.M., Rooke E.D. Defect of neuromuscular conduction associated with malignant neoplasms // Am. J. Physiol. - 1956. – V. 187. – P.612-616.

Lambert E.H., Lindstrom J., Lennon V.A. End-plate potentials in experimental autoimmune myasthenia gravis in rats // Ann. N.Y. Acad. Sci. - 1976. - V.274. - P.300-318.

Lambert E.H., Rooke E.D., Eaton L.M., Hodgson G. Myasthenic syndrome occasionally associated with bronchial neoplasm: neurophysiological studies // Myasthena gravis. - Springfield. - 1961. - P.362-410.

Lang B., Newsom-Davis J. Immunopathology of the Lambert-Eaton myasthenic syndrome // Springer Seminars in Immunopathology - 1995. - V.17. - P. 3-15.

Lang B., Newsom-Davis J., Wray D., Vincent A., Murray. N. Autoimmune aetiology for myasthenic (Eaton–Lambert) syndrome // Lancet. – 1981. – V. 2. – P.224–226.

Lang B., Pinto A., Giovannini F., Newsom-Davis J., Vincent A. Pathogenic autoantibodies in the Lambert-Eaton myasthenic syndrome // Ann. N.Y. Acad. Sci. - 2003. - V.998. - P.187-195.

Lang B, Vincent A, Murray N.M, Newsom-Davis J. Lambert-Eaton myasthenic syndrome: immunoglobulin G inhibition of calcium flux in tumor cells correlates with disease severity // Ann. Neurol. – 1989. – V. 25. – P.265-271.

Lang B., Waterman S., Pinto A., Jones D., Moss F., Boot J., Brust P., Williams M., Stauderman K., Harpold M., Motomura M., Moll J.W., Vincent A., Newsom-Davis J. The role of autoantibodies in Lambert–Eaton myasthenic syndrome // Ann. N.Y. Acad. Sci. – 1998. – V.841. – P.598–605.

Lauritzen M., Smith T., Fischer-Hansen B., Sparup J., Olesen J. Eaton-Lambert syndrome and malignant thymoma // Neurol. – 1980. – V.30. – P.634-638.

LeGolvan D.P., Abell M.R. Thymomas // Cancer. - 1977. - V.39. - №5 - P.2142-2157.

Leite M.I., Strobel P., Jones M. et al. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG // Ann. Neurol. – 2005. – V.57. - №3. – P.444-448.

Lennon V.A. Serological diagnosis of myasthenia gravis and Lambert- Eaton myasthenic syndrome // Handook of Myasthenia gravis / R. Lisak, Ed., Marcel Dekker. - 1994. - V.7. - P.149-164.

Lennon V.A. Serological profile of myasthenia gravis and distinction from the Lambert-Eaton myasthenic syndrome // Neurology. – 1997. – V.48. - №5. – P.23-27.

Lennon V.A., Ermilov L.G., Szurszewski J.H., Vernino S. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease // J. Clin. Invest. - 2003. - V.111. – P.907-913.

Lennon V.A., Kryzer Th.J., Griesmann G.E., O’Suilleabhain P.E., Windebank A.J., Woppmann A., Miljanich G.P., Lambert E.H. Calcium channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes // N.Engl. J. Med. - 1995. - V.332. - P.1467-1474.

ссылка скрыта Remission rate after thymectomy in myasthenia gravis when the bias of immunosuppressive therapy is eliminated // Acta Neurol. Scand. – 1992. – V.86. – P.323-328.

Lindstrom J. Antibody specificities in autoimmune myasthenia gravis // Neuromuscular Diseases / Serratrice G., Desnuelle C. (Eds.). - N.Y. - 1984. - P.481-495.

Lindstrom J. Neuronal nicotinic acetylcholine receptors // In: Ion Channels/ Ed. by Toshio Narahashi. N.Y. - Plenum Press. - 1996. - V.4. - Р.337-450.

Lindstrom J. Nicotinic Acetylcholine receptors in Health and Disease // Molecular Neurobiology. - 1997. - V.15. - №2. - Р.193-222.

Lindstrom J. Structure of neuronal nicotinic receptor // In: Neuronal nicotinic receptor / Ed: Clementi F., Fornasari D., Gotti C. - Berlin Heidelberg. – Springer-Verlag. - 2000. - V.144. - Р.101-162.

Lindstrom J. Acetylcholine receptor and myasthenia //Muscle & Nerve. - 2000. - № 23. - P.453-477.

Lindstrom J. Is "seronegative" MG explained by autoantibodies to MuSK? // Neurol. – 2004. – V.62. - P.1920-1931.

Lindstrom J., Lambert E.H. Content of acetylcholine receptor and antibodies bound to receptor to myasthenia gravis, experimental autoimmune myasthenia gravis and Eaton-Lambert syndrome // Neurol. (Minneap.). - 1978. - V.28. - P.130-138.

Lindstrom J., Lennon V.A., Seybold M., Whittingham S. Experimental autoimmune myasthenia and myasthenia gravis: biochemical and immunological aspects // Ann. N.Y. Acad. Sci. - 1976. - V.274. - P.254-274.

Lindstrom J., Shelton D., Fujii Y. Myasthenia gravis // Adv. Immunol. - 1988. - V.42. - P.233-284.

ссылка скрыта Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis // Acta Neurol. Scand. Suppl. – 1994. – V.158. – P.1-58.

ссылка скрыта Organ-specific autoantigens induce interferon-gamma and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis // Neurol. – 1994. – V.44. - №4. – P.728-734.

Lisak R. Myasthenia Gravis // In: Surgery of the thymus/ Ed. J.-C. Givel. - Berlin. Springer Verlang. - 1990. - P.165-181.

Luebke E., Freiburg A., Skeie G.O., Kolmerer B., Labeit S., Aarli J.A., Gilhus N.E. Striational autoantibodies in miasthenia gravis patients recognize I-band titin epitopes // J. Neuroimmunol. – 1988. – V.81. - №1-2. – P.98-108.

Maddison P., Newsom-Davis J., Mills K.R. Distribution of electrophysiological abnormality in Lambert-Eaton myasthenic syndrome // J. Neurol. Neurosurg. Psychiatry. - 1998. – V.65. - P.213-217.

ссылка скрыта Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus // Virchows Arch. Pathol. Anat. Histopathol. - 1985. – V.407. – P.119-149.

Martin-Moutot N., El Far O., Leveque C. et al. Synaptotagmin: a Lambert-Eaton myasthenic syndrome antigen that associates with presynaptic calcium channels // J. Physiol. – 1993. – V.87. – P.37-41.

Marx A., Osborne M., Tzartos S. et al. // A striational muscle antigen and myasthenia gravis- associated thymomas share an acetylcholine receptor epitope // Dev. Immunol. - 1992. - V.2 - P.77-83.

Maruyama K. Connectin, an elastic protein of striated muscle // Biophys. Chem. - 1994. - V.50. - P.73-85.

Maruyama K. Connectin / titin, giant elastic protein of muscle // FASEB J. - 1997. - V.11. - P.341-345.

ссылка скрыта Extended thymectomy for myasthenia gravis patients: a 20-year review // Ann. Thorac. Surg. – 1996. – V.62. – P.853-859.

Matsumoto R., Motomura M., Yoshimura T., Kohara N., Kato T. Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy // Rinsho Shinkeigaku. – 1999. – V.39. - №5. – P.531-537.

ссылка скрыта Detection and characterization of MuSK antibodies in seronegative myasthenia gravis // Ann. Neurol. – 2004. – V.55. - №4. – P.580-584.

ссылка скрыта Diagnosis and treatment of Lambert-Eaton myasthenic syndrome // Neurol. Clin. – 1994. – V.12. – P.387-399.

Meager A., Wadhwa M., Dilger P., Bird C., Thorpe R., Newsom-Davis J., Willcox N. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis // Clin Exp Immunol. - 2003. - V.132. - №1. - P.128-136.

Milone M., Wang H-L, Ohno K. et al. Slow-channel syndrome caused by enhanced activation, desensitization, and agonist binding affinity due to mutation in the M2 domain of the acetylcholine receptor - subunit // J. Neurosci. – 1997. – V.17. – P. 5651-5665.

Monden Y., Nakahara K, Nanijo S. Et al. Invasive thymoma with myastenia gravis // Cancer. – 1984. – V.54. - P.2513-2518.

Mossman S. Vincent A, Newsom-Davis J. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity // Lancet. – 1986. – V.18. - №1. – P.116-119.

Motomura M., Johnston I., Lang B., Vincent A., Newsom-Davis J. An improved diagnostic assay for Lambert–Eaton myasthenic syndrome // J. Neurol., Neurosurg., Psychiat. – 1995. – V.58. – P.85–87.

Motomura M., Lang B., Johnston I., Palace J., Vincent A., Newsom-Davis J. Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome // J. Neurol. Sci. – 1997. – V.147. – P.35-42.

Muller-Hermilink H., Marino M., Palestro G. Pathology of thymic epithelial tumors // The Human Thimyc / Ed. H. Muller-Hermilink.-Berlin, etc.: Springer Verlag. - 1986. - P.207-269.

Muller-Hermelink H., Marx A., Geuder K., Kirchner T. The pathological basis of thymoma-associated myasthenia gravis // Ann. N.Y. Acad. Sci. - 1994. - V.681. - P.56-65.

ссылка скрыта Congenital end-plate acetylcholine receptor deficiency and short channel open time // Ann. N.Y. Acad. Sci. – 1993. - V.681. - P.509-514.

ссылка скрыта Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis // Am. J. Med. – 1959. – V.26. - №3. – P.394-409.

Negri S., Caraceni T. Myasthenia gravis: parameters the motor unit potentials and modifications induced by endrophonium chloride // Clinical studies in myology / B.A. Kakulas (Ed.), - Amsterdam: Excerpta medica. - 1973. - P.381-395.

Nemoto Y., Kuwabara S., Misawa S., Kawaguchi N., Hattori T., Takamori M., Vincent A. Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis // J. Neurol., Neurosurg., Psychiat. – 2005. – V.76. - №5. – P.714-718.

Newsom-Davis J. Lambert-Eaton myasthenic syndrome // Springer semin. Immunopathol. - 1985. - P.129-140.

Oberman W.M., Gautel M., Weber K., Furst D.O. Molecular structure of the sarcomeric M band: mapping of titin and myosin binding domains in myomesin and the identification of a protein regulatory phosphorylation site in myomesin // EMBO J. – 1997. – V.16. – P.211-220.

Oda K. Differences in acetylcholine receptor antibody interactions between extraocular and extremity muscle fiber // Ann. N.Y. Acad. Sci. - 1993. - V.681. - P.238-255.

Oh S.J. Clinical electromyography // Baltimore. - 1982. - 519 p.

Oh S.J. Electromyography Neuromuscular Transmittion Studies // Baltimore. - 1988. - V.1. - 18 p.

Oh S.J. Repetitive nerve stimulation test // Methods in Clin. Neurophys. - 1992. - V.3. - №1. - 17 p.

Oh S.J. Electrophysiological characteristics in seronegative myasthenia gravis // Ann. N.Y. Acad. Sci. - 1993. - V.681. - P.584-587.

Oh S.J., Dwyer D.S., Bradley R.J. Overlap myasthenic syndrome: combined myasthenia gravis and Eaton-Lambert syndrome // Neurology. - 1987. – V. 37. – P.1411-1414.

Oh S.J., Kim D.E., Kuruoglu R., Brooks J., Claussen G. Electrophysiological and clinical correlations in the Lambert-Eaton myasthenic syndrome // Muscle & Nerve. - 1996. – V.19. – P.903-906.

Oh S.J., Kuruoglu R Chronic limb-girdle myasthenia gravis // Neurol. – 1992. – V.42. – P.1153-1156.

Oh S.J., Sher E. MG and LEMS overlap syndrome: case report with electrophysiological and immunological evidence // Clin. Neurophysiol. – 2005. – V.116. - №5. – P.1167-1171.

Ohta K., Shigemoto K., Kubo S., Maruyama N., Abe Y., Ueda N., Ohta M. MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG // Neurology. – 2004. – V.62. – P.2132-2133.

Olanow C.W., Lane R.J.M., Roses A.D. Thymectomy in juvenile myasthenia gravis // Neurol. - 1981. - V.31. - P.97.

O’Neill J., Murray N., Newsom-Davis J. The Lambert-Eaton myasthenic syndrome. A review of 50 cases // Brain. - 1988. - V.111. - P.577-596.

Oosterhuis H. Studies in myasthenia gravis. 1. A clinical study of 180 patients // J. Neurol. Sci. – 1964. – V.38. – P.512-546.

Oosterhuis H. Myasthenia Gravis // New York, 1984.

Oosterhuis H., Hootsmans W., Veenhuyzen H.B., Zadelhoff J. The mean duration of motor unit action potentials in patients with myasthenia gravis // Electroenceph. Clin. Neurophysiol. – 1972. - V.32. - P.697-700.

Osserman K.E. Myasthenia Gravis // New York. - 1958. - P.78-87.

Ouchi M., Konnai T., Shimizu M., Shibuya T., Suzuki H. Results and problems of thymectomy in myasthenia gravis over 65 years old // Kyobu Geka. - 1999. - V.52. - №13. - P.1095-1000.

Ozdemir C., Young R.R. Electrical testing in myasthenia gravis // Ann. N.Y. Acad. Sci. - 1972. - V.183. - P.278-302.

Ozdemir C., Young R.R. The results to be expected from electrical testing in the diagnosis of myasthenia gravis // Ann. N.Y. Acad. Sci. - 1980. - V.274. - P.203-222.

Patrick J., Lindstrom J., Culp B., McMillan J. Studies of purified AChR and antiacetylcholine receptor antibodies // Proc. Nat. Acad. Sci. - 1973. - V.70. - P.3334-3338.

Penn A.S., Scotland D.L., Rowland L.P. Immunology of muscle diseases // Res. Publ. Assoc. Res. Nerv. Ment. - 1971. - V.49. - P.215-240.

ссылка скрыта Tertiary structure of an immunoglobulin-like domain from the giant muscle protein titin: a new member of the I set // Structure. – 1995. – V.15. - №4. – P.391-401.

Ragheb S., Mohamed M., Lisak R.P. Myasthenia gravis patients, but not healthy subjects, recognize epitopes that are unique to the epsilon-subunit of the acetylcholine receptor // J. Neuroimmunol. – 2005. – V.159. - №1-2. – P.1137-1145.

ссылка скрыта., ссылка скрыта., ссылка скрыта., ссылка скрыта., ссылка скрыта., ссылка скрыта., ссылка скрыта., ссылка скрыта., ссылка скрыта. World Health Organization histologic classification: an independent prognostic factor in resected thymomas // Lung Cancer. – 2005. – V.50. – P.59-66.

Romi F., Gilhus N.E., Aarli J.A. Thymectomy and muscle antibodies in myasthenia gravis // Tidsskr. Nor. Laegeforen. – 2004. – V.124. - №5. – P.629-631.

Romi F., Gilhus N.E., Varhaug J.E., Myking A., Skeie G.O., Aarli J.A. Thymectomy and anti-muscle autoantibodies in late-onset myasthenia gravis // Eur. J. Neurol. - 2002. – V.1. - P.55-61.

Romi F., Gilhus N.E., Varhaug J.E., Myking A., Skeie G.O., Aarli J.A. Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis // Ann N Y Acad Sci. - 2003. – V.998. - P.481-490.

Romi F., Gilhus N.E., Aarli J.A. Myasthenia gravis: clinical, immunological and therapeutic advances // Acta Neurol. Scand. – 2005. – V.111. - №2 – P.134-141.

ссылка скрыта Myasthenia gravis: disease severity and prognosis // Acta Neurol. Scand. – 2006. – V.183. – P.24-25.

Romi F., Kristoffersen E.K., Aarli J.A., Gilhus N.E. The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo // J. Neuroimmunol. – 2005. – V.158. - №1-2. – P.191-194.

Romi F., Skeie G.O., Aarli J.A., Gilhus N.E. The severity myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.// Arch Neurol. – 2000. – V. 57. – P.1596-1600.

Romi F., Skeie G.O., Gilhus N.E., Aarli J.A. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.// Arch Neurol. – 2005. – V.62. – P.442-446.

Rosai J., Levin G. Tumors of the Thymus // Atlas of tumor pathology. - Washington: Armed Forces Inst. Of Pathol. - 1976. - P.26-33, 133-137.

Roses A.D., Olanov C.W., McAdams M.W., Lane R. No direct correlation between serum antyacetylcholine receptor antibody levels and clinical state of individual patient with myasthenia gravis // Neurology. – 1981. – V.31. – P.220-224.

Rowland L.P. Controversies about the treatment of myasthenia gravis// J. Neurol., Neurosurg., Psychiat. - 1980. - V.43. - P.644-659.

Sahashi K.A., Engel A.G., Lindstrom J., Lambert E.H., Lennon V.A. Ultrastructural localization of immune complexes (Ig G and C3) at the end-plate in experimental autoimmune myasthenia gravis // Neurol. - 1978. - V.37. - P.212-223.

Sanders D.B., El-Salem K., Massey J.M., McConville J., Vincent A. Clinical aspects of MuSK antibody positive seronegative MG // Neurology. – 2003. – V.24. - №12. – P.1978-1980.

ссылка скрыта Thymoma without myasthenia gravis: electrophysiological study after thymectomy // J. Neurol., Neurosurg., Psychiat. – 1988. – V.51. – P.160-161.

ссылка скрыта 3,4-Diaminopyridine in Lambert-Eaton myasthenic syndrome and myasthenia gravis // Ann N.Y. Acad. Sci. – 1993. – V.681. - P.588-590.

Satiamurti S., Drachman D.B., Slone F. Blocade of acetylcholine receptors: a model of myasthenia gravis // Science. - 1975. - V.187. - P.954-957.

Scadding G.K., Thomas H.C., Havard C.W. The immunological effects of thymectomy in myasthenia gravis // Clin. Experim. Immunol. - 1979. - V.36. - P.205-213.

Schulze W., Laczkovics A., Richl J., Sindern E. Thymectomy in myasthenia gravis - an analisis of current status // Chirurg. - 1998. - V.69. - №12. - P.1345-1351.

Sela B.A. Titin: some aspects of the largest protein in the body // Harefuah. – 2002. – V.131. – P. 631-635.

Selcen D., Fukuda T., Shen X.M., Engel A.G. Are MuSK antibodies the primary cause of myasthenic symptoms? // Neurol. – 2004. – V.62. - №11. – P.1945-1950.

Seybold M.E., Lindstrom J.M. Serial antiacetylcholine receptor antibody titers in patients with myasthenia gravis: effects of steroid therapy // Plasmapheresis and the immunology of myasthenia gravis / Dau P.C. (Ed.). - 1979. - P.307-314.

ссылка скрыта Selective impairment of serum antibody repertoires toward muscle and thymus antigens in patient with myasthenia gravis // J. Immunol. – 1998. – V.28. - №8. – P.2344-2354.

Sher E., Codignola A., Passafaro M., Tarroni P., Magnelli V., Carbone E., Clementi F. Nicotinic receptors and calcium channels in small cell lung carcinoma: functional role, modulation, and autoimmunity // Ann. N.Y. Acad. Sci. - 1998. – V.841. – P.606-624.

ссылка скрыта Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor // Int. Immunol. – 2003. – V.15. - №8. – P.903-913.

Shiraishi H., Motomura M., Yoshimura T., Fukudome T., Fukuda T., Nakao Y., Tsujihata M., Vincent A., Eguchi K. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis // Ann Neurol. - 2005. – V.57. - №2. – P.289-293.

Simpson J.A. Myasthenia gravis, a new hypothesis // Scotland Med. J. - 1960. - V.5. - P.419-436.

Skeie G.O. Skeletal muscle titin: physiology and pathophysiology // Cell. Mol. Life Sci. – 2000. – V. 57. – P. 1570-1576.

Skeie G.O., Mygland A., Aarli J., Gilhus N.E. Titin antibodies in patients with late-onset myasthenia gravis: clinical correlations // Autoimmunity. – 1995. – V.20. – P. 99-104.

Skeie G.O., Romi F., Aarli J.A., Bentsen P.T., Gilhus N.E. Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies // Ann N.Y. Acad. Sci. - 2003. – V.

Copyright © 2023. All rights Reserved.